Keyphrases
Airway
33%
Airway Microbiome
9%
Antibiotic Administration
12%
Antibiotics
11%
Asthma
19%
Azithromycin
100%
Bacteremia
8%
Blood Culture
100%
Blood Culture Collection
11%
Bronchiolitis
9%
Child's Family
33%
Clinical Outcomes
9%
Clinical Trials
69%
Collection Method
33%
Day 14
12%
Design Characteristics
66%
Effective Intervention
9%
Emergency Department
47%
Emergency Department Length of Stay
11%
Emergency Patients
26%
Group-randomized Trial
9%
Health Systems
33%
Healthy Participants
9%
Hospital Course
13%
In-person Visits
9%
Individualized Feedback
11%
Length of Stay
20%
Matrix metalloproteinase-9 (MMP-9)
33%
Microbial Composition
19%
Nasal Wash
9%
Nine-level
33%
No Significant Difference
12%
Nursing Education
11%
Pediatric Diseases
8%
Pediatric Emergency Department
50%
Peripheral Blood
50%
Placebo
22%
Placebo-controlled
9%
Positive Blood Culture
8%
Preschool Years
9%
Quality Improvement Initiatives
11%
Recurrent Wheeze
80%
Repeat Blood Cultures
13%
Respiratory Syncytial Virus
72%
Respiratory Syncytial Virus Bronchiolitis
100%
Significant Risk Factors
12%
Therapeutic Change
9%
Treatment Phase
9%
Upper Airway
24%
Wheezing
72%
Medicine and Dentistry
Asthma
12%
Azithromycin
100%
Blood Culture
66%
Bloodstream Infection
9%
Bronchiolitis
100%
Clinical Trial
69%
Consultation
8%
Emergency Department
66%
Gelatinase B
33%
Health Care
33%
Human Respiratory Syncytial Virus
100%
Microbiome
9%
Pediatrics
33%
Placebo
20%
Population Research
72%
Wheeze
100%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
12%
Azithromycin
100%
Bronchiolitis
100%
Clinical Trial
69%
Gelatinase B
33%
Human Respiratory Syncytial Virus
100%
Microbiome
9%
Placebo
20%
Population Study
66%
Wheezing
100%